Semble Raises €34.7M Series C for Healthcare Platform Expansion

Semble, a London-based innovator in healthcare management technology, has successfully closed a €34.7 million Series C funding round. This significant capital infusion is earmarked for expanding its sophisticated platform designed to streamline operations for outpatient healthcare providers across the UK and France. The investment underscores a growing demand for integrated digital solutions that can address the increasing complexities within modern healthcare delivery.

Leading the charge in this funding round was European growth equity firm Revaia, demonstrating strong conviction in Semble's market position and future potential. Joining Revaia as a new investor is Partech, further validating the company's trajectory. Crucially, the round also saw continued financial commitment from existing backers Mercia Ventures and Octopus Ventures, highlighting their sustained belief in Semble's mission and execution capabilities.

The European healthcare sector is undergoing a profound transformation, driven by technological advancements, escalating patient volumes, and a noticeable shift towards private medical insurance and self-pay models. In this dynamic environment, Semble's platform offers a vital solution. It aims to orchestrate the entire patient journey, from initial contact through to treatment and follow-up, thereby enhancing efficiency and patient experience. The company reports that over 10 million patients have already benefited from care facilitated by clinicians utilizing its system.

Christoph Lippuner, CEO and co-founder of Semble, emphasized the inadequacy of fragmented, single-purpose software solutions that often exacerbate operational burdens for providers and create disjointed patient pathways. "What healthcare organizations truly require is intelligent orchestration across the entire care journey," Lippuner stated. "The practices and groups that will thrive in the coming decade are those delivering an exceptional end-to-end patient experience. This investment empowers us to accelerate that vision across the UK and Europe."

Semble's platform is built with interoperability at its core, seamlessly integrating with over 1,200 third-party tools spanning diagnostics, billing, laboratory services, and customer relationship management. This open architecture allows healthcare providers to consolidate disparate systems into a unified operational hub. The company serves a diverse clientele, including prominent names such as Nuffield Health, Welbeck, Midland Health, London Doctors Clinic, Modality, and ProblemShared, showcasing the platform's adaptability for various scales of healthcare organizations.

With the newly acquired capital, Semble plans to deepen its penetration within major healthcare groups, solidify its role as a central AI-driven orchestration layer for care delivery, and further establish its presence in the French market, where its platform has already achieved regulatory compliance. The company has also demonstrated robust internal growth, increasing its workforce by more than 50% since December 2024, signaling its readiness for accelerated expansion and product development.